Vaidya Sane Ayurved Laboratories Ltd

Vaidya Sane Ayurved Laboratories Ltd

₹ 188 -4.73%
02 May - close price
About

Incorporated in 2006, Vaidya Sane Ayurved Laboratories Ltd is the business of running
of hospitals & clinics, and sale of Ayurved based medicines[1]

Key Points

Business Overview:[1][2][3]
VSALL is a chain of Cardiac Care Clinics and hospitals that have 350+ Clinics, out of these 54 are company-owned, 62 are OPD’s Mini Clinic and 234 are franchised clinics. These are run by 450+ Ayurvedic Physicians. Company also has 2 hospitals viz. Madhavbaug Hospital, Khopoli (NABH Accredited) and Madhavbaug Hospital Nagpur.

  • Market Cap 198 Cr.
  • Current Price 188
  • High / Low 377 / 162
  • Stock P/E 60.4
  • Book Value 52.1
  • Dividend Yield 0.27 %
  • ROCE %
  • ROE %
  • Face Value 10.0

Pros

  • Company is almost debt free.

Cons

  • Stock is trading at 3.62 times its book value

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Trading Industry: Trading

Loading peers table ...

Half Yearly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2022 Mar 2023 Sep 2023
46 54 51
41 50 48
Operating Profit 4 4 3
OPM % 9% 7% 5%
1 1 1
Interest 0 0 0
Depreciation 1 1 2
Profit before tax 4 3 2
Tax % 27% 23% 25%
3 2 1
EPS in Rs 2.60 2.00 1.12
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 TTM
99 105
91 98
Operating Profit 9 6
OPM % 9% 6%
1 1
Interest 1 0
Depreciation 3 3
Profit before tax 6 4
Tax % 25%
5 3
EPS in Rs 4.59 3.12
Dividend Payout % 5%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: %
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: %
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: -20%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: %

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Sep 2023
Equity Capital 11 11
Reserves 30 44
0 4
14 10
Total Liabilities 55 69
21 26
CWIP 2 2
Investments 15 6
17 35
Total Assets 55 69

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023
0
1
-1
Net Cash Flow -1

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023
Debtor Days 22
Inventory Days
Days Payable
Cash Conversion Cycle 22
Working Capital Days -2
ROCE %

Shareholding Pattern

Numbers in percentages

Mar 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
66.34% 66.34% 66.34% 66.34% 66.34% 66.34% 66.34% 66.34%
33.67% 33.66% 33.68% 33.67% 33.67% 33.66% 33.66% 33.66%
No. of Shareholders 493464534595637731846881

Documents